![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Justenhoven Christina Obazee Ofure Brauch Hiltrud
Publisher: Future Medicine
ISSN: 1462-2416
Source: Pharmacogenomics, Vol.13, Iss.6, 2012-04, pp. : 659-675
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Menopausal hormone therapy: lower fracture risk, but at a cost?
Reactions Weekly, Vol. 1, Iss. 1409, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Hormone therapy in peri- and postmenopause and the risk of cancer
PHARMAKON, Vol. 3, Iss. 6, 2015-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
TIMP-1 predicts response to hormone therapy in breast cancer
Inpharma, Vol. 1, Iss. 1639, 2008-01 ,pp. :